More than 50% of persons living with HIV (PLWH) have depression. Co-morbid HIV and depression yield reduced rates of antiretroviral therapy (ART) adherence and higher rates of HIV viral progression and mortality. We hypothesized that patient and ART-specific factors are associated with depression 12 months after ART initiation.
This retrospective study included treatment-naïve PLWH initiating ART between January 2007 and December 2012 at the HIV clinic of the University of Alabama at Birmingham (Alabama, USA). In addition to baseline (at ART initiation) sociodemographic and clinical characteristics, PHQ9 scores (self-reported depression) were obtained both at baseline and while receiving ART at 12-month. Patients were categorized as having depression (PHQ score ≥10) or mild/no depression (score ≤9) and receiving Efavirenz or Non-Efavirenz-based regimens. Associations were examined using univariate and multivariable logistic regression analyses.
291 patients were included: 61 (21%) had depression at 12 months, 83% were male, 60% were Black/African American, and mean age was 35 years. Odds of depression were higher at baseline than at 12 months (30% vs 21%, p=0.003), more so in the Non-Efavirenz regimen (39% vs 24%, p<0.001) than in Efavirenz-based regimen (20% vs 17%, p=0.48). Differential baseline depression between the regimens (20% vs 39%, p<0.001) was indicative of channeling bias. Depression at 12 months was higher among uninsured patients (30/142=27%) than in public (4/22=18%) or privately insured (18/127=14%). Overall, baseline median PHQ score decreased from 6 to 3 at 12 months (Efavirenz: 4 vs 2, Non-efavirenz: 7.5. vs 4.0). In univariate analysis, recipients of the Efavirenz-based regimen were at lower odds of having 12-month depression than Non-efavirenz regimens (OR=-0.7, 95% CI 0.4-1.2) (Table 1); after adjusting for baseline depression (channeling bias), the difference in 12 month depression between the regimens decreased (OR=0.9; 95% CI: 0.5-1.8). In multivariable analysis, baseline depression (ORadjusted=7.6; 95% CI: 3.7 – 15.5) and lack of insurance (ORadjusted=2.8; 95% CI: 1.3 – 6.0) were significantly associated with greater odds of 12 month depression; no difference was observed between ART regimens (Table 1).
In addition to aggressively treating existing depression, initiating ART and enrolling PLWH in insurance has the potential to improve depression and HIV health outcomes.